Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-21-060540
Filing Date
2021-11-18
Accepted
2021-11-18 16:00:09
Documents
3
Period of Report
2021-11-18

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea150982-6k_nlspharm.htm 6-K 10331
2 NOTICE OF MEETING AND PROXY CARD FOR THE EXTRAORDINARY SHAREHOLDERS' MEETING TO ea150982ex99-1_nlspharm.htm EX-99.1 49776
3 GRAPHIC ex99-1_001.jpg GRAPHIC 777
  Complete submission text file 0001213900-21-060540.txt   62285
Mailing Address ALTER POSTPLATZ 2 STANS V8 CH-6370
Business Address ALTER POSTPLATZ 2 STANS V8 CH-6370 41-41-618-80-00
NLS Pharmaceutics Ltd. (Filer) CIK: 0001783036 (see all company filings)

EIN.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39957 | Film No.: 211424335
SIC: 2834 Pharmaceutical Preparations